Elekta signs agreement with US Oncology
6 September 2006 Stockholm, Sweden. Elekta has signed a three-year
agreement with US Oncology outlining pricing and terms and conditions for
supplying intensity modulated and image guided radiation therapy to the
healthcare service network members. US Oncology is the USA's largest
healthcare services network devoted exclusively to cancer treatment and
research, and a pioneer in community-based cancer care since 1993. The
network has over 850 affiliated physicians at 460 sites of services,
including 85 cancer centres, in 32 states. US Oncology delivers care to more
than half a million cancer patients each year — including over 15% of all
newly diagnosed U.S. cases. This agreement opens up the possibility for
members of US Oncology to acquire advanced digital linear accelerators from
Elekta, capable of intensity modulated radiation therapy (IMRT) and 3D X-ray
Volume Imaging for image-guided radiation therapy (IGRT), developed for
addressing the problems of organ movement and patient set-up uncertainties
in radiation therapy.
Through this agreement, US Oncology regional members can now include
Elekta as a vendor for consideration. The agreement parallels a current
agreement between US Oncology and IMPAC Medical Systems, an Elekta company,
covering software systems for improved efficiency across the spectrum of
cancer care. "We are proud to be associated with US Oncology and are
looking forward for this new opportunity to provide the network members with
the most advanced clinical solutions for IMRT and IGRT", said Anthony
De Carolis, CEO of Elekta, Inc. and President of Elekta operations in North
America. To top
|